CDC Caught Using False Data To Recommend Kids’ COVID Vaccine
The Centers for Disease Control and Prevention (CDC) showcased highly misleading data about the risk of COVID-19 to kids when its expert vaccine advisers voted to recommend vaccines for children under five years old.
The agency featured a pre-print study ranking causes of death in children when it presented data to its Advisory Committee on Immunization Practices (ACIP) earlier this month, after which the committee voted to recommend kids aged six months through four years get vaccinated for COVID-19. The study claimed to show that COVID-19 was a leading cause of death for children in the United States during the coronavirus pandemic, but observers quickly pointed out major flaws in the data which rendered it misleading.
The paper ranks COVID-19 as a top six cause of death for age brackets from 0-19, including under one year old, 1-4 years old, 5-9 years old, 10-14 years old and 15-19 years old. It’s unclear why the authors include 18- and 19-year-olds in pediatric data. A majority of the researchers involved in the paper are from the United Kingdom, where the age of majority is 18 in most jurisdictions.
However, one misleading aspect of the paper, as first pointed out by covid-georgia.com, is that it ranks cumulative COVID-19 deaths alongside annual rates for other causes for death. For instance, in the 1-4 age group, the paper ranks cumulative COVID-19 deaths as the 5th leading cause of death, ahead of heart disease and influenza. But further down the list, it ranks annual COVID-19 deaths in eighth. For every single age group, the cumulative COVID-19 death rate is more than double the annualized death rate.
Another big issue with the CDC data presentation is the conflation of deaths caused directly by COVID-19 versus those for which COVID-19 was just a “contributing” factor. The authors state “we only consider Covid-19 as an underlying (and not contributing) cause of death,” but that is false.
https://dailycaller.com/2022/06/27/cdc-kids-vaccine-covid-coronavirus-flawed-study-fda/